« Back
Home /
Abarelix

Abarelix

€1,120.00

Excl. VAT

Item no.	M13376-50mg
Manufacturer	AbMole
CASRN	183552-38-7
Amount	50mg
Category	Reagents & Chemicals Other Chemicals
Type	Chemicals
Specific against	other
Purity	>96%
Formula	C72H95ClN14O14
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	R3827; PPI 149
Available
Bioactivity information	Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence：Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2
mw	1416, 06
solubility	DMSO : ≥ 14.2 mg/mL

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

Listprice: €1,120.00

Price: €1,120.00

available

Delivery expected until 9/11/2025

Quantity:

Compare